[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-344935-105":59,"doc-detail-344935-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","life-history-enlightened-therapies-cell-cycle-mapping-to-identify-molecular-targets-to-prevent-hepatocellular-carcinoma","Life history enlightened therapies: cell cycle mapping to identify molecular targets to prevent hepatocellular carcinoma","","Life history enlightened therapies (LHETs) were designed to counter therapeutic resistance by targeting pathological cell-state transitions that enable evolutionary rescue. This study extends LHETs to cancer prevention by examining metabolic dysfunction-associated steatohepatitis (MASH)-induced hepatocellular carcinoma initiation, highlighting endocycling as a key life-history transition driven by mitotic skipping. Cell cycle mapping integrates multiplex immunofluorescence imaging with manifold learning to reveal cellular life histories and their molecular drivers, identifying Wee1, CDK2, and RAIDD.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/life-history-enlightened-therapies-cell-cycle-mapping-to-identify-molecular-targets-to-prevent-hepatocellular-carcinoma/344935/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/life-history-enlightened-therapies-cell-cycle-mapping-to-identify-molecular-targets-to-prevent-hepatocellular-carcinoma/344935.png","ImageObject",300,407,{"name":92,"@type":93},"Emma Wilson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of this paper on life history enlightened therapies?","Question",{"text":112,"@type":113},"To expand life history enlightened therapies from targeting therapeutic resistance to enabling cancer prevention, specifically for MASH-induced hepatocellular carcinoma initiation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Why is endocycling considered a keystone transition in hepatocellular carcinoma initiation?",{"text":117,"@type":113},"Because it promotes HCC initiation by allowing cells to undergo whole-genome duplication via mitotic skipping, worsening the disease-associated phenotype.",{"name":119,"@type":110,"acceptedAnswer":120},"How does cell cycle mapping identify molecular targets?",{"text":121,"@type":113},"It combines in situ multiplexed immunofluorescence imaging with manifold learning to visualize the life history of proliferating cells and proteins involved in transitions to pathological cell states.",{"name":123,"@type":110,"acceptedAnswer":124},"Which molecular factors were identified as driving pathological endocycling in human MASH tissues?",{"text":125,"@type":113},"The study identifies Wee1, CDK2, and RAIDD as molecular factors driving pathological endocycling, suggesting new therapeutic targets for pre-clinical investigation.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},344935,1790240997,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","1  \nEvolution, Medicine, and Public Health [2026] pp.1---13  \n[https://doi.org/10.1093/emph/eoag002](https://doi.org/10.1093/emph/eoag002)  \nAdvance access date 14 January 2026  \nLife history enlightened therapies: cell cycle mapping to identify molecular targets to prevent hepatocellular carcinoma  \nAnuraag Bukkuri 1 , 4 , Janet McLaughlin1 , Andrew W. Duncan2 , 3 and Wayne Stallaert1 , *  \n1 Department of Computational and Systems Biology, Hillman Cancer Center, Center for Evolutionary Biology and Medicine, University of Pittsburgh, Pittsburgh, PA, USA; 2 Department of Pathology, McGowan Institute for Regenerative Medicine, Pittsburgh Liver Research Center, University of Pittsburgh School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA; 3 Department of Bioengineering, School of Engineering, University of Pittsburgh, Pittsburgh, PA, USA; and 4 Department of Mathematics, City St George’s, University of London, London, UK  \n* Corresponding author. Department of Computational and Systems Biology, Hillman Cancer Center, Center for Evolutionary  \nBiology and Medicine, University of Pittsburgh, Pittsburgh, PA, USA. Tel: 9195792798. E-mail: [stallaert@pitt.edu](stallaert@pitt.edu)[ ](stallaert@pitt.edu)Received 10 September 2025; revised version accepted 7 January 2026 .  \nABSTRACT  \nBackground and objectives: Life history enlightened therapies (LHETs) were originally developed in cancer to combat therapeutic resistance by targeting pathological cell state transitions that enable evolutionary rescue and adaptation to therapy. In this paper, we expand the scope of LHETs to cancer prevention, namely, metabolic dysfunction-associated steatohepatitis (MASH)-induced hepatocellular carcinoma (HCC) initiation. We focus on endocycling, a process wherein cells undergo whole-genome duplication via mitotic skipping, as a keystone life history transition that promotes HCC initiation. Methodology: A key obstacle to LHET translation is the lack of systematic methods that capture cellular life histories and their molecular drivers. To address this gap, we introduce cell cycle mapping, a technique that integrates in situ multiplexed immunofluorescence imaging with manifold learning to visualize the life history of proliferating cells and proteins involved in transitions to pathological cell states.  \nResults: Mathematical modeling demonstrated how endocycling can create an environment that promotes HCC initiation and revealed the potential for endocycle-targeting therapies to prevent HCC. Using cell cycle mapping on human MASH liver tissues, we identified the molecular factors that drive pathological endocycling (Wee1, CDK2, and RAIDD), providing new therapeutic targets for pre-clinical investigation.  \n© The Author(s) 2026 . Published by Oxford University Press on behalf of the Foundation for Evolution, Medicine, and Public Health.  \nThis is an Open Access article distributed under the terms of the Creative Commons Attribution License ([https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.  \nConclusions and implications: This application illustrates how cell cycle mapping can uncover key proteins that drive disease-associated cell state transitions and broaden the scope of LHETs from therapy resistance to cancer prevention. More broadly, our study establishes a generalizable pipeline for inferring the life history of cells in diseased tissues and potential interventions for disease management. Lay Summary: MASH is a leading cause of HCC and is associated with senescence, inflammation, and fibrosis. Endocycling exacerbates this phenotype and contributes to MASH progression. Cell cycle mapping can reveal the molecular factors that drive endocycling and suggest novel drug targets to stall MASH progression and prevent HCC initiation.  \nKEYWORDS: life history enlightened therapi","cbCaifVcPNWhfWCW","https://ap.wps.com/l/cbCaifVcPNWhfWCW","pdf",1296792,13,"English","# Abstract\n# Background and objectives\n# Methodology\n# Results\n# Conclusions and implications\n# Lay Summary\n# Keywords","[{\"question\":\"What is the main goal of this paper on life history enlightened therapies?\",\"answer\":\"To expand life history enlightened therapies from targeting therapeutic resistance to enabling cancer prevention, specifically for MASH-induced hepatocellular carcinoma initiation.\"},{\"question\":\"Why is endocycling considered a keystone transition in hepatocellular carcinoma initiation?\",\"answer\":\"Because it promotes HCC initiation by allowing cells to undergo whole-genome duplication via mitotic skipping, worsening the disease-associated phenotype.\"},{\"question\":\"How does cell cycle mapping identify molecular targets?\",\"answer\":\"It combines in situ multiplexed immunofluorescence imaging with manifold learning to visualize the life history of proliferating cells and proteins involved in transitions to pathological cell states.\"},{\"question\":\"Which molecular factors were identified as driving pathological endocycling in human MASH tissues?\",\"answer\":\"The study identifies Wee1, CDK2, and RAIDD as molecular factors driving pathological endocycling, suggesting new therapeutic targets for pre-clinical investigation.\"}]","Life history enlightened therapies: cell cycle mapping to identify molecular targets to prevent hepatocellular carcinoma | PDF",1790055828,33,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fc0420e5c5b14df8bace4386bf212f2f.webp",983,1291,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/17c599de1f7fc6395a39e019667ddc8e.webp",982,1290,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5f17c023ca4135a0561a7c09b3349899.webp",981,1289,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/113572a2d541c8615b23798b3eee5a8d.webp",980,1287]